InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (3 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Ali-Jackson Kamil, Directeur Juridique. Director active across 4 companies, notably Aclaris Therapeutics, Inc.. In total, 14 reports have been published. Split: 1 buy · 3 sells. Total volume traded: €317k. Activity tracked since 3 May 2021. The latest transaction was filed on 26 May 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Ali-Jackson Kamil
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
2,500 sharesCommon StockSEC:0000905148-26-003076:0
2,500 shares@ US$29.170.012% mcap100.0% of flowCommon StockSEC:0000905148-26-002724:0
5,750 shares0Common StockSEC:0000905148-26-002529:0
2,500 shares0Common StockSEC:0000905148-25-001935:0
25,000 shares0Common StockSEC:0000905148-24-001651:0
25,000 shares0Common StockSEC:0001140361-23-034284:0
18,750 shares0Common StockSEC:0001140361-22-020303:0
3,875 sharesCommon StockSEC:0001209191-22-001712:0
7,500 shares0Common StockSEC:0001209191-21-066084:0
11,764 shares@ US$8.50100.0% of flowCommon StockSEC:0001140361-21-021497:0
Canonical exit: 13 Sept 2021 (T+90)
9,492 shares@ US$21.957539.3% of flowCommon StockSEC:0001209191-21-038442:0
33,189 sharesCommon StockSEC:0001209191-21-037482:0
15,000 shares@ US$10.6630.3% of flowCommon StockSEC:0001209191-21-031038:0
15,000 shares@ US$10.6630.3% of flowCommon StockSEC:0001209191-21-030491:0
14 of 14 declarations
About Ali-Jackson Kamil
Ali-Jackson Kamil is the Legal Director at Aclaris Therapeutics, Inc. He oversees the legal affairs of the company.
